Cancel
Nikhil Lalwani
President and Chief Executive Officer
@
ANI Pharmaceuticals
About Nikhil Lalwani
Nikhil Lalwani is the President and CEO with a background in engineering and business, having held significant roles at Cipla Ltd and McKinsey & Company.
Known information
Nikhil Lalwani currently serves as the President and Chief Executive Officer, bringing a robust background in engineering and strategic leadership in the pharmaceutical sector. He worked at Cipla Ltd from May 2012 to August 2020, where he ascended through several key positions including CEO of Cipla USA, CEO of InvaGen, Head of US Strategy, M&A & Integration, and Head of Cipla’s Global Respiratory business. Prior to his tenure at Cipla, Lalwani was an Associate Partner at McKinsey & Company, where he provided consultancy services to global pharmaceutical and healthcare companies. His foundational career began as an engineer at Medtronic. Academically, Lalwani is well-prepared with a B.S. in Electrical Engineering from the Georgia Institute of Technology and an M.B.A. from the Wharton School at the University of Pennsylvania.
About ANI Pharmaceuticals
ANI Pharmaceuticals, based in Baudette, Minnesota, specializes in both branded and generic prescription pharmaceuticals, offering a range of products and services including manufacturing and packaging of various dosage forms.
Report inaccurate information
